Conditions: HIV Infections
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 445
Healthy volunteers: no

Brief summary:
The primary objective of this study is to demonstrate the efficacy of nevirapine extended release (NVP XR) based regimen for HIV-1 infected patients who were receiving nevirapine immediate release (NVP IR) based regimen for at least 18 prior weeks of therapy.

Detailed description:

Arms:
arm 1: 200 mg orally twice a day (po BID) arm 2: 400 mg orally once a day (po QD)

Interventions: intervention 1: Nevirapine XR intervention 2: Nevirapine XR intervention 3: Nevirapine IR
Intervention descriptions: intervention 1: Nevirapine XR intervention 2: Nevirapine extended release intervention 3: Nevirapine Immediate Release

Protocol document: